Format
Sort by
Items per page

Send to

Choose Destination

Best matches for multiple sclerosis:

Multiple sclerosis - etiology and diagnostic potential. Kamińska J et al. Postepy Hig Med Dosw (Online). (2017)

Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function. Ontaneda D et al. Lancet. (2017)

Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Correale J et al. Brain. (2017)

Search results

Items: 1 to 20 of 81125

2.

[Optical Coherence Tomography in Disorders of the Central Nervous System].

Papadopoulou A, Oertel FC, Zimmermann H, Zeitz O, Brandt AU, Paul F.

Klin Monbl Augenheilkd. 2018 Nov;235(11):1242-1258. doi: 10.1055/a-0715-7961. Epub 2018 Nov 20. German.

PMID:
30458564
3.

Cerebellum and cognition in multiple sclerosis.

Schreck L, Ryan S, Monaghan P.

J Neurophysiol. 2018 Dec 1;120(6):2707-2709. doi: 10.1152/jn.00245.2018. Epub 2018 Aug 15.

PMID:
30457471
4.

Evidence for oestrogen sensitivity in perinatal depression: pharmacological sex hormone manipulation study.

Mehta D, Rex-Haffner M, Søndergaard HB, Pinborg A, Binder EB, Frokjaer VG.

Br J Psychiatry. 2018 Nov 20:1-9. doi: 10.1192/bjp.2018.234. [Epub ahead of print]

PMID:
30457060
5.

The level of evidence of medical marijuana use for treating disabilities: a scoping review.

Stetten N, Pomeranz J, Moorhouse M, Yurasek A, Blue AV.

Disabil Rehabil. 2018 Nov 20:1-12. doi: 10.1080/09638288.2018.1523952. [Epub ahead of print]

PMID:
30456993
6.

Microglial modulation through colony-stimulating factor-1 receptor inhibition attenuates demyelination.

Wies Mancini VSB, Pasquini JM, Correale JD, Pasquini LA.

Glia. 2018 Nov 19. doi: 10.1002/glia.23540. [Epub ahead of print]

PMID:
30456797
7.

Association of SHMT1, MAZ, ERG, and L3MBTL3 Gene Polymorphisms with Susceptibility to Multiple Sclerosis.

Nazari Mehrabani SZ, Shushizadeh MH, Abazari MF, Nouri Aleagha M, Ardalan A, Abdollahzadeh R, Azarnezhad A.

Biochem Genet. 2018 Nov 19. doi: 10.1007/s10528-018-9894-1. [Epub ahead of print]

PMID:
30456721
8.

Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model.

Sun L, Telles E, Karl M, Cheng F, Luetteke N, Sotomayor EM, Miller RH, Seto E.

Life Sci Alliance. 2018 Sep 24;1(5):e201800039. doi: 10.26508/lsa.201800039. eCollection 2018 Oct.

PMID:
30456376
9.

Color vision testing versus pattern visual evoked potentials and optical coherence tomography parameters in subclinical optic nerve involvement in multiple sclerosis.

Yuksel B, Dogan B, Koctekin B, Atis N, Erdal A, Kurtulus F, Erol MK, Gomceli YB.

J Clin Neurosci. 2018 Nov 16. pii: S0967-5868(18)30451-X. doi: 10.1016/j.jocn.2018.11.011. [Epub ahead of print]

PMID:
30455132
10.

Adolescent and parent factors related to fatigue in paediatric multiple sclerosis and chronic fatigue syndrome: A comparative study.

Carroll S, Chalder T, Hemingway C, Heyman I, Bear H, Sweeney L, Moss-Morris R.

Eur J Paediatr Neurol. 2018 Nov 2. pii: S1090-3798(18)30016-3. doi: 10.1016/j.ejpn.2018.10.006. [Epub ahead of print]

PMID:
30455131
11.

Ten-year trends of palliative care utilization associated with multiple sclerosis patients in the United States from 2005 to 2014.

Lee YJ, Yoo JW, Hua L, Kim PC, Kim SJ, Shen JJ.

J Clin Neurosci. 2018 Dec;58:13-19. doi: 10.1016/j.jocn.2018.10.082. Epub 2018 Oct 24.

PMID:
30454687
12.

Outcomes of Bariatric Surgery in Patients with Multiple Sclerosis.

Burn S, Stone A, Strange S, Seip R, Tishler D, McLaughlin T, Papasavas P.

Am Surg. 2018 Mar 1;84(3):e104-e105. No abstract available.

PMID:
30454424
13.

The physiology of foamy phagocytes in multiple sclerosis.

Grajchen E, Hendriks JJA, Bogie JFJ.

Acta Neuropathol Commun. 2018 Nov 19;6(1):124. doi: 10.1186/s40478-018-0628-8. Review.

PMID:
30454040
14.

Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report.

Myro AZ, Bjerke G, Zarnovicky S, Holmøy T.

BMC Pharmacol Toxicol. 2018 Nov 19;19(1):75. doi: 10.1186/s40360-018-0267-5.

PMID:
30454022
15.

Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells.

Saliba SW, Jauch H, Gargouri B, Keil A, Hurrle T, Volz N, Mohr F, van der Stelt M, Bräse S, Fiebich BL.

J Neuroinflammation. 2018 Nov 19;15(1):322. doi: 10.1186/s12974-018-1362-7.

PMID:
30453998
16.

Moral Judgment: An Overlooked Deficient Domain in Multiple Sclerosis?

Ayache SS, Chalah MA.

Behav Sci (Basel). 2018 Nov 16;8(11). pii: E105. doi: 10.3390/bs8110105. Review.

PMID:
30453483
17.

Reactive astrocytes in multiple sclerosis impair neuronal outgrowth through TRPM7-mediated chondroitin sulfate proteoglycan production.

Kamermans A, Planting KE, Jalink K, van Horssen J, de Vries HE.

Glia. 2018 Nov 19. doi: 10.1002/glia.23526. [Epub ahead of print]

PMID:
30453391
18.

Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis.

Crescenzo F, Marastoni D, Zuco C, Pitteri M, Magliozzi R, Monaco S, Calabrese M.

Mult Scler Relat Disord. 2018 Nov 12;27:305-311. doi: 10.1016/j.msard.2018.11.009. [Epub ahead of print]

PMID:
30453199
19.

Lower self-report fatigue in multiple sclerosis is associated with localized white matter tract disruption between amygdala, temporal pole, insula, and other connected structures.

Fuchs TA, Vaughn CB, Benedict RHB, Weinstock-Guttman B, Choudhery S, Carolus K, Rooney P, Ashton K, P Ramasamy D, Jakimovski D, Zivadinov R, Dwyer MG.

Mult Scler Relat Disord. 2018 Nov 9;27:298-304. doi: 10.1016/j.msard.2018.11.005. [Epub ahead of print]

PMID:
30453198
20.

Predictive PBPK modeling as a tool in the formulation of the drug candidate TMP-001.

Nothnagel L, Jung F, Rossmanith T, Thurn M, Ashtikar M, Geisslinger G, Parnham MJ, Wacker MG.

Eur J Pharm Biopharm. 2018 Nov 16. pii: S0939-6411(18)30854-3. doi: 10.1016/j.ejpb.2018.11.012. [Epub ahead of print]

PMID:
30453024

Supplemental Content

Loading ...
Support Center